MiniMed Group, Inc. ((MiniMed, NASDAQ:MMED), a global leader in insulin delivery, announced Health Canada has licensed new software for the MiniMed™ 780G system, marking a meaningful step forward in diabetes care for Canadians. With this authorization, the MiniMed™ 780G system now offers greater flexibility, combining Meal Detection™ technology, and SmartGuard™, with both the Guardian™ 4 and Simplera Sync™ sensors. Additionally, the system is now compatible with Fiasp® and indicated for adults 18 years and older with Type 2 diabetes.

Simplera Sync™ is a disposable, all-in-one sensor that requires no fingersticks* with SmartGuard, no overtape, and features a simple, two-step insertion process, introducing a more comfortable wear experience while reducing the daily burden of diabetes management.